Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

HISTORICAL FACTS: Armata pharmaceuticals earnings perspective return on capital employed - Caught on Camera

Benzinga Pro data, Armata Pharmaceuticals (AMEX:ARMP) reported Q4 sales of $989.00 thousand. Earnings fell to a loss of $6.05 million, resulting in a 11.59% decrease from last quarter. Armata Pharmaceuticals collected $1.25 million in revenue during Q3, but reported earnings showed a $5.42 million loss.

What Is Return On Capital Employed?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.